Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2009 1
2011 1
2012 2
2013 1
2014 2
2015 3
2016 2
2017 1
2018 2
2019 2
2020 3
2021 7
2022 9
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Recent advances in radiotherapy of breast cancer.
Haussmann J, Corradini S, Nestle-Kraemling C, Bölke E, Njanang FJD, Tamaskovics B, Orth K, Ruckhaeberle E, Fehm T, Mohrmann S, Simiantonakis I, Budach W, Matuschek C. Haussmann J, et al. Among authors: mohrmann s. Radiat Oncol. 2020 Mar 30;15(1):71. doi: 10.1186/s13014-020-01501-x. Radiat Oncol. 2020. PMID: 32228654 Free PMC article. Review.
Post-Neoadjuvant Treatment Strategies in Breast Cancer.
Matuschek C, Jazmati D, Bölke E, Tamaskovics B, Corradini S, Budach W, Krug D, Mohrmann S, Ruckhäberle E, Fehm T, Nestle Krämling C, Dommach M, Haussmann J. Matuschek C, et al. Among authors: mohrmann s. Cancers (Basel). 2022 Feb 28;14(5):1246. doi: 10.3390/cancers14051246. Cancers (Basel). 2022. PMID: 35267554 Free PMC article. Review.
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Nitz U, Gluz O, Graeser M, Christgen M, Kuemmel S, Grischke EM, Braun M, Augustin D, Potenberg J, Krauss K, Schumacher C, Forstbauer H, Reimer T, Stefek A, Fischer HH, Pelz E, Zu Eulenburg C, Kates R, Wuerstlein R, Kreipe HH, Harbeck N; WSG-ADAPT investigators. Nitz U, et al. Lancet Oncol. 2022 May;23(5):625-635. doi: 10.1016/S1470-2045(22)00159-0. Epub 2022 Apr 8. Lancet Oncol. 2022. PMID: 35405088 Clinical Trial.
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI.
Jannusch K, Dietzel F, Bruckmann NM, Morawitz J, Boschheidgen M, Minko P, Bittner AK, Mohrmann S, Quick HH, Herrmann K, Umutlu L, Antoch G, Rubbert C, Kirchner J, Caspers J. Jannusch K, et al. Among authors: mohrmann s. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1451-1461. doi: 10.1007/s00259-023-06513-9. Epub 2023 Dec 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 38133687 Free PMC article.
Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis.
Krawczyk N, Röwer R, Anlauf M, Muntanjohl C, Baldus SE, Neumann M, Banys-Paluchowski M, Otten S, Luczak K, Ruckhäberle E, Mohrmann S, Hoffmann J, Kaleta T, Jaeger B, Esposito I, Fehm T. Krawczyk N, et al. Among authors: mohrmann s. Geburtshilfe Frauenheilkd. 2021 Nov 18;82(1):68-84. doi: 10.1055/a-1557-1280. eCollection 2022 Jan. Geburtshilfe Frauenheilkd. 2021. PMID: 35027862 Free PMC article.
Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients.
Krawczyk N, Jaeger B, Martina PJ, Cristina LR, Melissa N, Maggie BP, Franziska MS, Hans N, Dieter N, Eugen R, Svjetlana M, Jürgen H, Thomas K, Irene E, Tanja F. Krawczyk N, et al. Among authors: svjetlana m. Arch Gynecol Obstet. 2024 Apr;309(4):1525-1533. doi: 10.1007/s00404-023-07225-z. Epub 2023 Oct 30. Arch Gynecol Obstet. 2024. PMID: 37902839 Free PMC article.
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning.
Morawitz J, Sigl B, Rubbert C, Bruckmann NM, Dietzel F, Häberle LJ, Ting S, Mohrmann S, Ruckhäberle E, Bittner AK, Hoffmann O, Baltzer P, Kapetas P, Helbich T, Clauser P, Fendler WP, Rischpler C, Herrmann K, Schaarschmidt BM, Stang A, Umutlu L, Antoch G, Caspers J, Kirchner J. Morawitz J, et al. Among authors: mohrmann s. J Nucl Med. 2023 Feb;64(2):304-311. doi: 10.2967/jnumed.122.264138. Epub 2022 Sep 22. J Nucl Med. 2023. PMID: 36137756 Free PMC article.
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, Ruckhäberle E, Mohrmann S, Häberle L, Ingenwerth M, Abrar DB, Sawicki LM, Breuckmann K, Fendler WP, Herrmann K, Buchbender C, Antoch G, Umutlu L, Kirchner J. Morawitz J, et al. Among authors: mohrmann s. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):992-1001. doi: 10.1007/s00259-021-05502-0. Epub 2021 Sep 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34476552 Free PMC article.
44 results